Bandaram Pharma Packtech Limited has announced a significant corporate action, involving a substantial acquisition of equity shares by its promoters and persons acting in concert.

Key Details of the Share Acquisition

• Prajitha Bandaram acquired 486,480 shares through preferential allotment on November 6, 2025.
• The company's equity share capital increased from Rs. 12.00 crores (1.20 crore shares of Rs. 10 each) to Rs. 17.97 crores (1.79 crore shares of Rs. 10 each) after the acquisition.

Promoter Group Holdings

Following this acquisition, the promoter group's holdings include:

Regulatory Compliance

The disclosure was filed under SEBI regulations for substantial acquisition of shares and takeovers, ensuring transparency in the company's ownership structure.

Implications

This move by Bandaram Pharma Packtech's promoters indicates a commitment to the company. The change in shareholding structure may potentially influence the company's operations and decision-making processes.

Stakeholders may observe how Bandaram Pharma Packtech utilizes this increased promoter stake in its future strategies and market positioning within the pharmaceutical packaging industry.

Bandaram Pharma Packtech Limited has announced key corporate decisions following its board meeting held on September 5, 2025. The company's Board of Directors has approved several important matters, including the reappointment of its Chairman and Managing Director and the scheduling of its Annual General Meeting (AGM) for the fiscal year 2024-25.

Leadership Continuity

The board has approved the re-appointment of Mr. Deepak Reddy Bandaram (DIN: 07074102) as the Chairman and Managing Director of the company. This reappointment is for a term of three years, effective from February 7, 2026. However, it is important to note that this decision is subject to shareholder approval at the upcoming Annual General Meeting.

Annual General Meeting Details

Bandaram Pharma Packtech has scheduled its Annual General Meeting for the financial year 2024-25 on Monday, September 29, 2025, at 11:00 a.m. In line with modern corporate practices, the AGM will be conducted via video conference or other audio-visual means (OAVM), allowing shareholders to participate remotely.

Board Meeting Outcomes

The board meeting, which commenced at 11:00 a.m. and concluded at 11:45 a.m., was held at the company's registered office. During this meeting, the Board of Directors also approved the Directors' Report for the financial year 2024-25.

Regulatory Compliance

These announcements were made in compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015.

Bandaram Pharma Packtech Limited operates in the pharmaceutical packaging sector. The company's corporate identity number is L93090KA1993PLC159827, indicating its registration in Karnataka, India.

Investors and stakeholders are advised to take note of these important corporate updates, particularly the upcoming AGM and the proposed reappointment of the company's Chairman and Managing Director.